|
Simulations Plus, Inc. (SLP) DCF Valuation
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Simulations Plus, Inc. (SLP) Bundle
Enhance your investment choices with the (SLP) DCF Calculator! Explore authentic Simulations Plus financial data, adjust growth estimates and expenses, and instantly observe how modifications influence the intrinsic value of (SLP).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.6 | 46.5 | 53.9 | 59.6 | 70.0 | 79.8 | 90.9 | 103.6 | 118.0 | 134.5 |
| Revenue Growth, % | 0 | 11.73 | 16.01 | 10.52 | 17.52 | 13.94 | 13.94 | 13.94 | 13.94 | 13.94 |
| EBITDA | 11.9 | 14.7 | 18.5 | 12.6 | 11.8 | 21.1 | 24.1 | 27.4 | 31.2 | 35.6 |
| EBITDA, % | 28.5 | 31.63 | 34.29 | 21.09 | 16.85 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 |
| Depreciation | 3.0 | 3.6 | 3.6 | 3.8 | 5.7 | 5.7 | 6.5 | 7.5 | 8.5 | 9.7 |
| Depreciation, % | 7.12 | 7.73 | 6.63 | 6.45 | 8.09 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 |
| EBIT | 8.9 | 11.1 | 14.9 | 8.7 | 6.1 | 15.4 | 17.5 | 20.0 | 22.7 | 25.9 |
| EBIT, % | 21.38 | 23.9 | 27.66 | 14.64 | 8.76 | 19.27 | 19.27 | 19.27 | 19.27 | 19.27 |
| Total Cash | 116.0 | 123.6 | 128.2 | 115.5 | 20.3 | 68.4 | 78.0 | 88.9 | 101.2 | 115.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 10.5 | 13.1 | 13.8 | 10.2 | 9.1 | 17.4 | 19.8 | 22.6 | 25.8 | 29.3 |
| Account Receivables, % | 25.28 | 28.09 | 25.58 | 17.12 | 13.05 | 21.82 | 21.82 | 21.82 | 21.82 | 21.82 |
| Inventories | 1.0 | 1.0 | 1.4 | .8 | .0 | 1.3 | 1.5 | 1.7 | 2.0 | 2.3 |
| Inventories, % | 2.33 | 2.18 | 2.58 | 1.35 | 0 | 1.69 | 1.69 | 1.69 | 1.69 | 1.69 |
| Accounts Payable | .4 | .4 | .2 | .1 | .6 | .5 | .6 | .7 | .8 | .9 |
| Accounts Payable, % | 0.84397 | 0.83287 | 0.41739 | 0.2417 | 0.85984 | 0.63916 | 0.63916 | 0.63916 | 0.63916 | 0.63916 |
| Capital Expenditure | -2.6 | -4.6 | -4.0 | -4.3 | -.6 | -5.0 | -5.7 | -6.5 | -7.4 | -8.4 |
| Capital Expenditure, % | -6.21 | -9.85 | -7.36 | -7.17 | -0.80842 | -6.28 | -6.28 | -6.28 | -6.28 | -6.28 |
| Tax Rate, % | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 |
| EBITAT | 7.3 | 9.8 | 12.3 | 7.4 | 4.9 | 12.9 | 14.6 | 16.7 | 19.0 | 21.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.5 | 6.3 | 10.6 | 11.1 | 12.3 | 3.9 | 12.9 | 14.7 | 16.8 | 19.1 |
| WACC, % | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 52.1 | |||||||||
| Long Term Growth Rate, % | 3.90 | |||||||||
| Free cash flow (T + 1) | 20 | |||||||||
| Terminal Value | 511 | |||||||||
| Present Terminal Value | 351 | |||||||||
| Enterprise Value | 404 | |||||||||
| Net Debt | -9 | |||||||||
| Equity Value | 413 | |||||||||
| Diluted Shares Outstanding, MM | 20 | |||||||||
| Equity Value Per Share | 20.34 |
What You Will Get
- Real SLP Financial Data: Pre-filled with Simulations Plus’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Simulations Plus’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Simulations Plus, Inc. (SLP).
- Adjustable Forecast Parameters: Modify highlighted cells to tailor WACC, growth rates, and margins to your needs.
- Real-Time Calculations: Experience automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Utilize user-friendly charts and summaries to effectively visualize your valuation outcomes.
- Suitable for All Skill Levels: Designed with a straightforward, intuitive layout for investors, CFOs, and consultants alike.
How It Works
- 1. Access the Model: Download and open the Excel file containing Simulations Plus, Inc. (SLP) preloaded data.
- 2. Adjust Parameters: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
- 5. Present with Assurance: Deliver professional valuation insights that enhance your decision-making process.
Why Choose Simulations Plus, Inc. (SLP)?
- Streamlined Processes: Get instant access to powerful simulation tools without the hassle of setup.
- Enhanced Precision: Utilize cutting-edge algorithms and data to minimize errors in drug development.
- Highly Adaptable: Customize simulations to align with your specific research needs and goals.
- User-Friendly Interface: Intuitive design and visual outputs facilitate straightforward analysis.
- Respected by Industry Leaders: Trusted by pharmaceutical experts who prioritize accuracy and effectiveness.
Who Should Use Simulations Plus, Inc. (SLP)?
- Pharmaceutical Researchers: Utilize advanced simulation tools to model drug interactions and outcomes.
- Academic Institutions: Enhance curriculum with state-of-the-art pharmacokinetic and pharmacodynamic models.
- Regulatory Agencies: Assess drug efficacy and safety through robust simulations before clinical trials.
- Biotech Companies: Optimize drug development processes with customizable simulation software.
- Healthcare Professionals: Understand and predict patient responses to treatments using simulation data.
What the Template Contains
- Pre-Filled DCF Model: Simulations Plus, Inc.’s (SLP) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Simulations Plus, Inc.’s (SLP) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.